Though artificial bioactive compounds are permitted in lots of nations for meals functions, they’re changing into much less and fewer welcome by customers. Due to this fact, there was an growing curiosity in changing these artificial compounds by pure bioactive compounds. These pure compounds can be utilized as meals components to take care of the meals high quality, meals security and attraction, and as meals dietary supplements or nutraceuticals to right dietary deficiencies, keep an appropriate consumption of vitamins, or to assist physiological capabilities, respectively.
Latest research reveal that quite a few meals wastes, significantly fruit and greens byproducts, are a very good supply of bioactive compounds that may be extracted and reintroduced into the meals chain as pure meals components or in meals matrices for acquiring nutraceuticals and purposeful meals. This evaluation addresses common questions regarding using fruit and greens byproducts as new sources of pure bioactive compounds which can be being addressed to meals as pure components and dietary supplements. These bioactive compounds should observe the authorized necessities and evaluations to evaluate the dangers for human well being and their toxicity should be thought-about earlier than being launched into the market.
To beat the potential well being danger whereas growing the organic exercise, stability and biodistribution of the dietary supplements’ technological options have been studied comparable to encapsulation of bioactive compounds into micro or nanoparticles or nanoemulsions. It will permit enhancing the soundness and launch alongside the gastrointestinal tract in a managed method into the precise tissues. This evaluation summarizes the valorization path {that a} bioactive compound recovered from an agro-food waste can face from the second their potentialities are exhibited till it reaches the ultimate client and the protection and toxicity challenges, they could overcome.
Preclinical Bioavailability, Tissue Distribution, and Protein Binding Research of Erinacine A, a Bioactive Compound from Hericium erinaceus Mycelia Utilizing Validated LC-MS/MS Methodology
Erinacine A, derived from the mycelia of Hericium erinaceus, has attracted a lot consideration because of its neuroprotective properties. Nevertheless, only a few research have been carried out on the bioavailability, tissue distribution, and protein binding of erinacine A. This research aimed to analyze the bioavailability, tissue distribution, and protein binding of erinacine A in Sprague-Dawley rats. After oral administration (po) and intravenous administration (iv) of two.381 g/kg BW of the H. erinaceus mycelia extract (equal to 50 mg/kg BW of erinacine A) and 5 mg/kg BW of erinacine A, respectively, absolutely the bioavailability of erinacine A was estimated as 24.39%.
Erinacine A was detected in mind at 1 h after oral dosing and reached the height at eight h. Protein binding assay confirmed unbound erinacine A fractions in mind to blood ratio is near unity, supporting passive diffusion because the dominating transport. Feces was the foremost route for the elimination of erinacine A. This research is the primary to indicate that erinacine A can penetrate the blood-brain barrier of rats by the technique of passive diffusion and thus assist the event of H. erinaceus mycelia for the development of neurohealth.
Enzymatic pretreatment of seeds is a novel method that enhances the well being advantages of the extracted oil. The research investigated the affect of the enzymatic pretreatment of seeds on the standard of oil from totally different pomegranate cultivars. The standard of the ultrasound-assisted (and ethanol-extracted) oil was studied, with respect to the refractive index (RI), yellowness index (YI), conjugated dienes (Ok232), peroxide worth (PV) ρ-anisidine worth (AV), whole oxidation worth (TOTOX), whole carotenoid content material (TCC), whole phenolic compounds (TPC), fatty acid composition, phytosterol composition, ferric lowering antioxidant energy (FRAP), and a pair of.2-diphenyl-1-picryl hydrazyl (DPPH) radical scavenging capability.
Dedication of Bioactive Compounds in Sequential Extracts of Chia Leaf ( Salvia hispanica L.) Utilizing UHPLC-HRMS (Q-Orbitrap) and a World Analysis of Antioxidant In Vitro Capability
Shoppers’ curiosity in meals which can be nutritionally balanced and with well being advantages has elevated. The meals trade is being attentive to using the ancestral seed Salvia hispanica L., generally often known as chia. At current, solely chia seeds, that are a pure supply of omega-Three and omega-6, fiber, proteins, and pure antioxidants, are commercialized. Though some research reveal the presence of a number of bioactive compounds, comparable to polyphenols (e.g., vitexin, orientin, and a few hydroxycinnamic acids) in chia leaf methanolic extracts, the chia plant is usually used as fertilizer or handled as waste after harvest.
Due to this fact, it might symbolize a by-product that may very well be thought-about an incredible supply of bioactive compounds with unexplored potential in medication and meals trade functions. On this work, UHPLC-HRMS (Q-Orbitrap) was employed to tentatively determine and decide the bioactive compounds current in numerous leaf extracts of chia crops of black and white seed phenotype obtained with solvents of various polarity (ethanol, ethyl acetate, dichloromethane, and hexane) to handle chia plant by-product revalorization. The chemical antioxidant capability was additionally studied and correlated to the discovered bioactive compounds.
C8orf55 Protein Vector (Human) (pPB-C-His) |
|||
| PV066905 | ABM | 500 ng | EUR 662.4 |
C8orf55 Protein Vector (Human) (pPB-N-His) |
|||
| PV066906 | ABM | 500 ng | EUR 662.4 |
C8orf55 Protein Vector (Human) (pPM-C-His) |
|||
| PV066908 | ABM | 500 ng | EUR 662.4 |
C8orf55 3'UTR Luciferase Stable Cell Line |
|||
| TU002535 | ABM | 1.0 ml | EUR 1672.8 |
C8orf55 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K0261502 | ABM | 1.0 ug DNA | EUR 184.8 |
C8orf55 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K0261503 | ABM | 1.0 ug DNA | EUR 184.8 |
C8orf55 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K0261504 | ABM | 1.0 ug DNA | EUR 184.8 |
C8orf55 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K0261505 | ABM | 3 x 1.0 ug | EUR 451.2 |
C8orf55 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K0261506 | ABM | 1.0 ug DNA | EUR 200.4 |
C8orf55 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K0261507 | ABM | 1.0 ug DNA | EUR 200.4 |
C8orf55 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K0261508 | ABM | 1.0 ug DNA | EUR 200.4 |
C5orf26 (C5orf26) Antibody |
|||
| abx231120-100ug | Abbexa | 100 ug | EUR 577.2 |
C6ORF134 antibody |
|||
| 70R-1282 | Fitzgerald | 100 ug | EUR 452.4 |
|
Description: Rabbit polyclonal C6ORF134 antibody raised against the N terminal Of C6Orf134 |
|||
C1orf165 antibody |
|||
| 70R-13073 | Fitzgerald | 100 ul | EUR 548.4 |
|
Description: Affinity purified Rabbit polyclonal C1orf165 antibody |
|||
C1orf175 Antibody |
|||
| 48086-100ul | SAB | 100ul | EUR 399.6 |
C1orf175 Antibody |
|||
| 48086-50ul | SAB | 50ul | EUR 286.8 |
C1orf101 Antibody |
|||
| 46367-100ul | SAB | 100ul | EUR 302.4 |
C1orf106 Antibody |
|||
| 46368-100ul | SAB | 100ul | EUR 302.4 |
C9orf116 Antibody |
|||
| 47264-100ul | SAB | 100ul | EUR 302.4 |
C9orf156 Antibody |
|||
| 44873-100ul | SAB | 100ul | EUR 302.4 |
C9orf156 Antibody |
|||
| 44873-50ul | SAB | 50ul | EUR 224.4 |
C6ORF140 antibody |
|||
| 70R-2829 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6ORF140 antibody raised against the N terminal Of C6Orf140 |
|||
C9ORF127 antibody |
|||
| 70R-1830 | Fitzgerald | 100 ug | EUR 452.4 |
|
Description: Rabbit polyclonal C9ORF127 antibody raised against the C terminal Of C9Orf127 |
|||
C9ORF127 antibody |
|||
| 70R-1846 | Fitzgerald | 100 ug | EUR 452.4 |
|
Description: Rabbit polyclonal C9ORF127 antibody raised against the middle region of C9Orf127 |
|||
C1orf106 antibody |
|||
| 70R-16073 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal C1orf106 antibody |
|||
C1orf116 antibody |
|||
| 70R-16074 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal C1orf116 antibody |
|||
C9orf156 antibody |
|||
| 70R-16100 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal C9orf156 antibody |
|||
C1orf165 antibody |
|||
| 23150-100ul | SAB | 100ul | EUR 468 |
C6orf210 antibody |
|||
| 22198-100ul | SAB | 100ul | EUR 468 |
C6ORF146 antibody |
|||
| 70R-3608 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6ORF146 antibody raised against the middle region of C6Orf146 |
|||
C1ORF103 antibody |
|||
| 70R-3621 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF103 antibody raised against the middle region of C1Orf103 |
|||
C1ORF111 antibody |
|||
| 70R-3654 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF111 antibody raised against the N terminal Of C1Orf111 |
|||
C1ORF111 antibody |
|||
| 70R-3664 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF111 antibody raised against the middle region of C1Orf111 |
|||
C1ORF110 antibody |
|||
| 70R-3688 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF110 antibody raised against the N terminal Of C1Orf110 |
|||
C1ORF116 antibody |
|||
| 70R-3844 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF116 antibody raised against the middle region of C1Orf116 |
|||
C6ORF134 antibody |
|||
| 70R-3866 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6ORF134 antibody raised against the middle region of C6Orf134 |
|||
C1ORF177 antibody |
|||
| 70R-3886 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF177 antibody raised against the middle region of C1Orf177 |
|||
C6orf134 antibody |
|||
| 70R-3914 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6orf134 antibody raised against the N terminal of C6orf134 |
|||
C1orf104 antibody |
|||
| 70R-3998 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1orf104 antibody raised against the middle region of C1orf104 |
|||
C1orf144 antibody |
|||
| 70R-4008 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1orf144 antibody raised against the N terminal of C1orf144 |
|||
C1orf122 antibody |
|||
| 70R-4043 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1orf122 antibody raised against the n terminal of C1orf122 |
|||
C1orf102 antibody |
|||
| 70R-4047 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1orf102 antibody raised against the N terminal of C1orf102 |
|||
C1ORF131 antibody |
|||
| 70R-4090 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF131 antibody raised against the middle region of C1Orf131 |
|||
C6ORF150 antibody |
|||
| 70R-4145 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6ORF150 antibody raised against the middle region of C6Orf150 |
|||
C6ORF173 antibody |
|||
| 70R-4208 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6ORF173 antibody raised against the N terminal Of C6Orf173 |
|||
C6ORF199 antibody |
|||
| 70R-4250 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6ORF199 antibody raised against the N terminal Of C6Orf199 |
|||
C1ORF110 antibody |
|||
| 70R-4268 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF110 antibody raised against the middle region of C1Orf110 |
|||
C1ORF174 antibody |
|||
| 70R-4285 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF174 antibody raised against the middle region of C1Orf174 |
|||
C1ORF103 antibody |
|||
| 70R-4298 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF103 antibody raised against the N terminal Of C1Orf103 |
|||
C1ORF190 antibody |
|||
| 70R-4302 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF190 antibody raised against the middle region of C1Orf190 |
|||
C1ORF102 antibody |
|||
| 70R-3298 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF102 antibody raised against the N terminal Of C1Orf102 |
|||
C6ORF199 antibody |
|||
| 70R-3324 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6ORF199 antibody raised against the middle region of C6Orf199 |
|||
C9ORF153 antibody |
|||
| 70R-3503 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C9ORF153 antibody raised against the middle region of C9Orf153 |
|||
C9ORF138 antibody |
|||
| 70R-3538 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C9ORF138 antibody raised against the N terminal Of C9Orf138 |
|||
C9ORF117 antibody |
|||
| 70R-3540 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C9ORF117 antibody raised against the N terminal Of C9Orf117 |
|||
C1ORF142 antibody |
|||
| 70R-4385 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF142 antibody raised against the middle region of C1Orf142 |
|||
C6orf154 antibody |
|||
| 70R-4433 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6orf154 antibody raised against the N terminal of C6orf154 |
|||
C6ORF154 antibody |
|||
| 70R-4442 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6ORF154 antibody raised against the middle region of C6Orf154 |
|||
C6ORF201 antibody |
|||
| 70R-4814 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6ORF201 antibody raised against the N terminal Of C6Orf201 |
|||
C6ORF182 antibody |
|||
| 70R-3111 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6ORF182 antibody raised against the middle region of C6Orf182 |
|||
C6orf113 antibody |
|||
| 70R-8412 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal C6orf113 antibody |
|||
C1orf216 antibody |
|||
| 70R-9212 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal C1orf216 antibody |
|||
C6orf182 antibody |
|||
| 70R-9345 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal C6orf182 antibody |
|||
C1ORF184 antibody |
|||
| 70R-2168 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF184 antibody raised against the C terminal Of C1Orf184 |
|||
C1ORF166 antibody |
|||
| 70R-5998 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF166 antibody raised against the middle region of C1Orf166 |
|||
C6ORF192 antibody |
|||
| 70R-6602 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C6ORF192 antibody raised against the N terminal Of C6Orf192 |
|||
C1ORF166 antibody |
|||
| 70R-6681 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF166 antibody raised against the middle region of C1Orf166 |
|||
C1ORF151 antibody |
|||
| 70R-6832 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF151 antibody raised against the middle region of C1Orf151 |
|||
C9ORF127 antibody |
|||
| 70R-7003 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C9ORF127 antibody raised against the N terminal Of C9Orf127 |
|||
C1ORF159 antibody |
|||
| 70R-7031 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF159 antibody raised against the C terminal Of C1Orf159 |
|||
C9ORF127 antibody |
|||
| 70R-7095 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C9ORF127 antibody raised against the C terminal Of C9Orf127 |
|||
C1ORF159 antibody |
|||
| 70R-7421 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C1ORF159 antibody raised against the middle region of C1Orf159 |
|||
C6orf113 antibody |
|||
| 70R-7909 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal C6orf113 antibody |
|||
C9orf156 Antibody |
|||
| ABD2619 | Lifescience Market | 100 ug | EUR 525.6 |
C1orf103 Antibody |
|||
| abx231057-100ug | Abbexa | 100 ug | EUR 610.8 |
C1orf104 Antibody |
|||
| abx231058-100ug | Abbexa | 100 ug | EUR 577.2 |
C1orf156 Antibody |
|||
| abx231061-100ug | Abbexa | 100 ug | EUR 577.2 |
C1orf163 Antibody |
|||
| abx231062-100ug | Abbexa | 100 ug | EUR 610.8 |
C6orf130 Antibody |
|||
| abx231124-100ug | Abbexa | 100 ug | EUR 577.2 |
C6orf173 Antibody |
|||
| abx231127-100ug | Abbexa | 100 ug | EUR 577.2 |
C6orf182 Antibody |
|||
| abx231128-100ug | Abbexa | 100 ug | EUR 610.8 |
C6orf204 Antibody |
|||
| abx231129-100ug | Abbexa | 100 ug | EUR 577.2 |
C6orf211 Antibody |
|||
| abx231130-100ug | Abbexa | 100 ug | EUR 577.2 |
C9orf156 Antibody |
|||
| abx231143-100ug | Abbexa | 100 ug | EUR 577.2 |
C1orf123 Antibody |
|||
| 20-abx318425 | Abbexa |
|
|
C1orf161 Antibody |
|||
| abx146255-100ug | Abbexa | 100 ug | EUR 469.2 |
C1orf156 Antibody |
|||
| abx146257-100ug | Abbexa | 100 ug | EUR 469.2 |
C1orf111 Antibody |
|||
| abx146267-100ug | Abbexa | 100 ug | EUR 469.2 |
C1orf112 antibody |
|||
| 31835-100ul | SAB | 100ul | EUR 302.4 |
C1orf112 antibody |
|||
| 31835-50ul | SAB | 50ul | EUR 224.4 |
C9orf156 Antibody |
|||
| 20-abx002463 | Abbexa |
|
|
C6orf136 Antibody |
|||
| 1-CSB-PA713102LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C6orf136. Recognizes C6orf136 from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
C1orf111 Antibody |
|||
| 1-CSB-PA716346LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf111. Recognizes C1orf111 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
C1orf101 Antibody |
|||
| 1-CSB-PA719393LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf101. Recognizes C1orf101 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200 |
|||
C6orf141 Antibody |
|||
| 1-CSB-PA725558LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C6orf141. Recognizes C6orf141 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
C1orf189 Antibody |
|||
| 1-CSB-PA730130LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf189. Recognizes C1orf189 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
|||
C1orf158 Antibody |
|||
| 1-CSB-PA839778LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf158. Recognizes C1orf158 from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
C1orf127 Antibody |
|||
| 1-CSB-PA854077LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf127. Recognizes C1orf127 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
C9orf117 Antibody |
|||
| abx122983-100ug | Abbexa | 100 ug | EUR 469.2 |
C9orf156 Antibody |
|||
| 20-abx149327 | Abbexa |
|
|
C6orf168 Antibody |
|||
| abx146370-100ug | Abbexa | 100 ug | EUR 469.2 |
C6orf211 Antibody |
|||
| abx146371-100ug | Abbexa | 100 ug | EUR 469.2 |
C6orf106 Antibody |
|||
| abx146379-100ug | Abbexa | 100 ug | EUR 469.2 |
C6orf118 Antibody |
|||
| abx146394-100ug | Abbexa | 100 ug | EUR 469.2 |
C6orf190 Antibody |
|||
| abx146395-100ug | Abbexa | 100 ug | EUR 469.2 |
C9orf156 Antibody |
|||
| abx146414-100ug | Abbexa | 100 ug | EUR 469.2 |
C9orf114 Antibody |
|||
| abx146415-100ug | Abbexa | 100 ug | EUR 469.2 |
C9orf102 Antibody |
|||
| abx146425-100ug | Abbexa | 100 ug | EUR 469.2 |
C6orf223 Antibody |
|||
| 20-abx301118 | Abbexa |
|
|
C9orf163 Antibody |
|||
| 20-abx301522 | Abbexa |
|
|
C1orf127 Antibody |
|||
| 20-abx301622 | Abbexa |
|
|
C1orf189 Antibody |
|||
| 20-abx301998 | Abbexa |
|
|
C6orf136 Antibody |
|||
| 20-abx307509 | Abbexa |
|
|
C1orf111 Antibody |
|||
| 20-abx307539 | Abbexa |
|
|
C1orf158 Antibody |
|||
| 20-abx309398 | Abbexa |
|
|
C1orf210 Antibody |
|||
| 20-abx308482 | Abbexa |
|
|
C6orf211 Antibody |
|||
| abx028716-400ul | Abbexa | 400 ul | EUR 627.6 |
C6orf211 Antibody |
|||
| abx028716-80l | Abbexa | 80 µl | EUR 343.2 |
C6orf138 Antibody |
|||
| abx026241-400ul | Abbexa | 400 ul | EUR 627.6 |
C6orf138 Antibody |
|||
| abx026241-80l | Abbexa | 80 µl | EUR 343.2 |
C9orf156 Antibody |
|||
| abx033079-400ul | Abbexa | 400 ul | EUR 627.6 |
C9orf156 Antibody |
|||
| abx033079-80l | Abbexa | 80 µl | EUR 343.2 |
C1orf105 Antibody |
|||
| 1-CSB-PA003497LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf105. Recognizes C1orf105 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
C1orf106 Antibody |
|||
| 1-CSB-PA003498GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf106. Recognizes C1orf106 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
C9orf156 Antibody |
|||
| 1-CSB-PA004297GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C9orf156. Recognizes C9orf156 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
|||
C9orf163 Antibody |
|||
| 1-CSB-PA822739LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C9orf163. Recognizes C9orf163 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
C6orf223 Antibody |
|||
| 1-CSB-PA836654LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C6orf223. Recognizes C6orf223 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
|||
C1orf123 Antibody |
|||
| 1-CSB-PA873673LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf123. Recognizes C1orf123 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200 |
|||
C1orf112 Antibody |
|||
| 1-CSB-PA878881LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf112. Recognizes C1orf112 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
C1orf210 Antibody |
|||
| 1-CSB-PA808993LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf210. Recognizes C1orf210 from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
C6orf203 Antibody |
|||
| 1-CSB-PA889170LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C6orf203. Recognizes C6orf203 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
C6orf150 Antibody |
|||
| DF12574 | Affbiotech | 200ul | EUR 420 |
C1orf163 Antibody |
|||
| DF12866 | Affbiotech | 200ul | EUR 420 |
C9orf156 Antibody |
|||
| DF2619 | Affbiotech | 200ul | EUR 420 |
C1orf114 Antibody |
|||
| DF14271 | Affbiotech | 100ul | EUR 420 |
C1orf198 Antibody |
|||
| DF15087 | Affbiotech | 100ul | EUR 420 |
C6orf134 Antibody |
|||
| DF13487 | Affbiotech | 100ul | EUR 420 |
C9orf142 Antibody |
|||
| DF13585 | Affbiotech | 100ul | EUR 420 |
C14ORF130 antibody |
|||
| 70R-1154 | Fitzgerald | 100 ug | EUR 452.4 |
|
Description: Rabbit polyclonal C14ORF130 antibody raised against the C terminal Of C14Orf130 |
|||
C14ORF130 antibody |
|||
| 70R-1165 | Fitzgerald | 100 ug | EUR 452.4 |
|
Description: Rabbit polyclonal C14ORF130 antibody raised against the middle region of C14Orf130 |
|||
C14orf169 Antibody |
|||
| 43867-100ul | SAB | 100ul | EUR 302.4 |
C14orf180 Antibody |
|||
| 47536-100ul | SAB | 100ul | EUR 302.4 |
C14ORF172 antibody |
|||
| 70R-2828 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C14ORF172 antibody raised against the N terminal Of C14Orf172 |
|||
C10orf119 antibody |
|||
| 70R-16053 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal C10orf119 antibody |
|||
C14orf133 antibody |
|||
| 70R-16061 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal C14orf133 antibody |
|||
C14orf166 antibody |
|||
| 70R-16062 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal C14orf166 antibody |
|||
C20orf149 antibody |
|||
| 70R-16084 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal C20orf149 antibody |
|||
C14orf172 antibody |
|||
| 10R-1213 | Fitzgerald | 100 ug | EUR 614.4 |
|
Description: Mouse monoclonal C14orf172 antibody |
|||
C14orf169 antibody |
|||
| 10R-1463 | Fitzgerald | 100 ug | EUR 614.4 |
|
Description: Mouse monoclonal C14orf169 antibody |
|||
C14ORF174 antibody |
|||
| 70R-3593 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C14ORF174 antibody raised against the N terminal Of C14Orf174 |
|||
C20ORF144 antibody |
|||
| 70R-3770 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C20ORF144 antibody raised against the middle region of C20Orf144 |
|||
C20ORF141 antibody |
|||
| 70R-3827 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C20ORF141 antibody raised against the middle region of C20Orf141 |
|||
C20ORF195 antibody |
|||
| 70R-3953 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C20ORF195 antibody raised against the N terminal Of C20Orf195 |
|||
C14ORF140 antibody |
|||
| 70R-3954 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C14ORF140 antibody raised against the N terminal Of C14Orf140 |
|||
C20orf132 antibody |
|||
| 70R-4048 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C20orf132 antibody raised against the middle region of C20orf132 |
|||
C20ORF160 antibody |
|||
| 70R-4133 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C20ORF160 antibody raised against the N terminal Of C20Orf160 |
|||
C20ORF141 antibody |
|||
| 70R-4134 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C20ORF141 antibody raised against the middle region of C20Orf141 |
|||
C10ORF132 antibody |
|||
| 70R-4206 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C10ORF132 antibody raised against the N terminal Of C10Orf132 |
|||
C20ORF111 antibody |
|||
| 70R-4348 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C20ORF111 antibody raised against the N terminal Of C20Orf111 |
|||
C14ORF148 antibody |
|||
| 70R-3453 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C14ORF148 antibody raised against the middle region of C14Orf148 |
|||
C14ORF104 antibody |
|||
| 70R-4364 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C14ORF104 antibody raised against the N terminal Of C14Orf104 |
|||
C14ORF156 antibody |
|||
| 70R-4685 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C14ORF156 antibody raised against the N terminal Of C14Orf156 |
|||
C14orf126 antibody |
|||
| 70R-9183 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal C14orf126 antibody |
|||
C14orf177 antibody |
|||
| 70R-9355 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal C14orf177 antibody |
|||
C14orf129 antibody |
|||
| 70R-9457 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal C14orf129 antibody |
|||
C14ORF130 antibody |
|||
| 70R-2272 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C14ORF130 antibody raised against the N terminal Of C14Orf130 |
|||
C20ORF116 antibody |
|||
| 70R-6275 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C20ORF116 antibody raised against the middle region of C20Orf116 |
|||
C14ORF180 antibody |
|||
| 70R-6428 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C14ORF180 antibody raised against the middle region of C14Orf180 |
|||
C14ORF180 antibody |
|||
| 70R-6443 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C14ORF180 antibody raised against the N terminal Of C14Orf180 |
|||
C14ORF180 antibody |
|||
| 70R-6588 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C14ORF180 antibody raised against the N terminal Of C14Orf180 |
|||
C20ORF116 antibody |
|||
| 70R-7151 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal C20ORF116 antibody raised against the N terminal Of C20Orf116 |
|||
C20ORF100 antibody |
|||
| 70R-7817 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal C20ORF100 antibody |
|||
C14ORF101 antibody |
|||
| 70R-8031 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal C14ORF101 antibody |
|||
C10orf125 Antibody |
|||
| abx230996-100ug | Abbexa | 100 ug | EUR 577.2 |
C14orf102 Antibody |
|||
| abx231018-100ug | Abbexa | 100 ug | EUR 577.2 |
C14orf133 Antibody |
|||
| abx231019-100ug | Abbexa | 100 ug | EUR 577.2 |
C14orf138 Antibody |
|||
| abx231020-100ug | Abbexa | 100 ug | EUR 577.2 |
C14orf156 Antibody |
|||
| abx231021-100ug | Abbexa | 100 ug | EUR 577.2 |
C20orf112 Antibody |
|||
| abx231079-100ug | Abbexa | 100 ug | EUR 577.2 |
C20orf149 Antibody |
|||
| abx231080-100ug | Abbexa | 100 ug | EUR 577.2 |
C20orf152 Antibody |
|||
| abx231081-100ug | Abbexa | 100 ug | EUR 610.8 |
C20orf195 Antibody |
|||
| abx231084-100ug | Abbexa | 100 ug | EUR 577.2 |
C14orf115 Antibody |
|||
| abx146321-100ug | Abbexa | 100 ug | EUR 469.2 |
C14orf172 Antibody |
|||
| abx146330-100ug | Abbexa | 100 ug | EUR 469.2 |
C14orf149 Antibody |
|||
| abx146331-100ug | Abbexa | 100 ug | EUR 469.2 |
C14orf133 Antibody |
|||
| abx146332-100ug | Abbexa | 100 ug | EUR 469.2 |
C14orf126 Antibody |
|||
| abx146333-100ug | Abbexa | 100 ug | EUR 469.2 |
C14orf177 Antibody |
|||
| 1-CSB-PA703583LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C14orf177. Recognizes C14orf177 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:200-1:500 |
|||
In these experiments, black chia confirmed the next antioxidant capability than white chia within the ethanolic extracts. Furthermore, experiments on mobile antioxidant exercise have been additionally carried out with a predominance of the white chia extract. It’s famous that the mobile antioxidant exercise outcomes make chia ethanolic extracts promising antioxidants.